[Federal Register Volume 69, Number 166 (Friday, August 27, 2004)]
[Notices]
[Page 52697]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-19601]



[[Page 52697]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (DHHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public.

DATES: The meeting will be held on October 5, 2004, from 9 a.m. to 3:30 
p.m., and on October 6, 2004, from 9 a.m. to 3:30 p.m.

ADDRESSES: Department of Health and Human Services; Hubert H. Humphrey 
Building, Room 800; 200 Independence Avenue, SW., Washington, DC 20201.

FOR FURTHER INFORMATION, CONTACT: Ms. Emma English, Program Analyst, 
National Vaccine Program Office, Department of Health and Human 
Services, Room 725H Hubert H. Humphrey Building, 200 Independence 
Avenue, SW., Washington, DC 20201; (202) 690-5566, 
[email protected].

SUPPLEMENTARY INFORMATION: Pursuant to Section 2101 of the Public 
Service Act (42 U.S.C. 300aa-1), the Secretary of Health and Human 
Services was mandated to establish the National Vaccine Program (NVP) 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The Secretary designated the Assistant Secretary 
for Health to serve as the Director, NVPO. The National Vaccine 
Advisory Committee (NVAC) was established to provide advice and make 
recommendations to the Director, NVPO, on matters related to the 
program's responsibilities.
    Topics to be discussed at the meeting include: Pandemic Influenza 
and the Pandemic Influenza Response and Preparedness Plan and the NVAC 
Influenza Working Group's assessment of domestic influenza issues/
needs. Updates will be given on the NVAC Working Group on Public 
Participation, the NVAC Working Group on Vaccine Financing, the NVAC 
Vaccine Safety and Communications Subcommittee, the NVAC Futures 
Vaccines Subcommittee, and the NVAC Immunization Coverage Subcommittee. 
A tentative agenda will be made available on or about September 21 for 
review on the NVAC Web site: http://www.hhs.gov/nvpo/nvac.
    Public attendance at the meeting is limited to space available. 
Individuals must provide a photo ID for entry into the Humphrey 
Building. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the designated contact person. Members of 
the public will have the opportunity to provide comments at the 
meeting. Public comment will be limited to five minutes per speaker. 
Any members of the public who wish to have printed material distributed 
to NVAC members should submit materials to the Executive Secretary, 
NVAC, through the contact person listed above prior to close of 
business September 29, 2004. Preregistration is required for both 
public attendance and comment. Any individual who wishes to attend the 
meeting and/or participate in the public comment session should e-mail 
[email protected]

    Dated: August 24, 2004.
Sarah Landry,
Associate Director for Communication and Legislation, National Vaccine 
Program Office.
[FR Doc. 04-19601 Filed 8-26-04; 8:45 am]
BILLING CODE 4150-28-P